These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28150213)

  • 1. Artificial Antigen-Presenting Cells for Immunotherapies.
    Siefert AL; Fahmy TM; Kim D
    Methods Mol Biol; 2017; 1530():343-353. PubMed ID: 28150213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
    Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
    Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells.
    Steenblock ER; Fahmy TM
    Mol Ther; 2008 Apr; 16(4):765-72. PubMed ID: 18334990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.
    Kosmides AK; Meyer RA; Hickey JW; Aje K; Cheung KN; Green JJ; Schneck JP
    Biomaterials; 2017 Feb; 118():16-26. PubMed ID: 27940380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.
    Hanlon DJ; Aldo PB; Devine L; Alvero AB; Engberg AK; Edelson R; Mor G
    Am J Reprod Immunol; 2011 Jun; 65(6):597-609. PubMed ID: 21241402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
    Sun X; Han X; Xu L; Gao M; Xu J; Yang R; Liu Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
    Li H; Shao S; Cai J; Burner D; Lu L; Chen Q; Minev B; Ma W
    Immunology; 2017 Nov; 152(3):462-471. PubMed ID: 28664991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial antigen-presenting cells for use in adoptive immunotherapy.
    Turtle CJ; Riddell SR
    Cancer J; 2010; 16(4):374-81. PubMed ID: 20693850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
    Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
    J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
    Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
    Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.
    Zhang L; Wang L; Shahzad KA; Xu T; Wan X; Pei W; Shen C
    Cancer Immunol Immunother; 2017 Sep; 66(9):1229-1241. PubMed ID: 28501941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.
    Eggermont LJ; Paulis LE; Tel J; Figdor CG
    Trends Biotechnol; 2014 Sep; 32(9):456-65. PubMed ID: 24998519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of tumor antigens to dendritic cells using biodegradable microspheres.
    Waeckerle-Men Y; Gander B; Groettrup M
    Methods Mol Med; 2005; 109():35-46. PubMed ID: 15585911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology-Based Cancer Vaccine.
    Alshamsan A
    Methods Mol Biol; 2017; 1530():257-270. PubMed ID: 28150207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-Class II Artificial Antigen Presenting Cells in CD4
    Couture A; Garnier A; Docagne F; Boyer O; Vivien D; Le-Mauff B; Latouche JB; Toutirais O
    Front Immunol; 2019; 10():1081. PubMed ID: 31156634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic dendritic polymeric microspheres induce enhanced T cell activation and expansion for adoptive tumor immunotherapy.
    Yang H; Sun L; Chen R; Xiong Z; Yu W; Liu Z; Chen H
    Biomaterials; 2023 May; 296():122048. PubMed ID: 36842237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.